Cannabidiol Decreases Intestinal Inflammation in the Ovariectomized Murine Model of Postmenopause
Abstract Cannabidiol (CBD) (25 mg/kg peroral) treatment was shown to improve metabolic outcomes in ovariectomized (OVX) mice deficient in 17β-estradiol (E2). Herein, CBD effects on intestinal and hepatic bile acids